49 results
8-K
EX-99.2
AGIO
Agios Pharmaceuticals Inc
8 Jan 24
Agios Announces Key Anticipated 2024 Milestones Across Rare Disease Portfolio
7:58am
Assessment of Chronic Illness Therapy-Fatigue) subscale score from Week 12 to Week 24 Treatment with 100 mg mitapivat demonstrated statistically significant
8-K
EX-99.1
2k7edtqp8tiuqn9q6g
29 Jul 21
Agios Reports Business Highlights and Second Quarter 2021 Financial Results
7:17am
8-K
EX-99.2
32g5d7
11 Jun 21
Other Events
7:24am
8-K
EX-99.1
73o2uz1om3l6uu
26 Jan 21
Other Events
4:14pm
DEFA14A
i7k2ojps
12 Jan 21
Additional proxy soliciting materials
5:15pm
DEFA14A
EX-99.2
t4o 5m5bdr
21 Dec 20
Additional proxy soliciting materials
7:10am
8-K
EX-99.2
yvxzzsnwuu6a92i
21 Dec 20
Regulation FD Disclosure
7:04am
8-K
EX-99.1
hu6fjeubo3ql2ifxbr
1 Dec 20
Other Events
7:46am
8-K
EX-99.3
fk1q2x7e68 ykocbck
12 Jun 20
Entry into a Material Definitive Agreement
7:04am